{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:08:17Z","timestamp":1790510897811,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.neurobiolaging.2010.04.024","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T08:41:30Z","timestamp":1276332090000},"page":"1263-1274","source":"Crossref","is-referenced-by-count":123,"title":["The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort"],"prefix":"10.1016","volume":"31","author":[{"given":"A.","family":"Caroli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410380414","article-title":"Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease","volume":"38","author":"Arai","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib3","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0306-4522(99)00476-5","article-title":"The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease","volume":"95","author":"Bobinski","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib4","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib5","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000280577.43413.d9","article-title":"Trajectories of brain loss in aging and the development of cognitive impairment","volume":"70","author":"Carlson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(03)14469-8","article-title":"Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study","volume":"362","author":"Chan","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.21955","article-title":"Relationship between atrophy and beta-amyloid deposition in Alzheimer disease","volume":"67","author":"Ch\u00e9telat","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib9","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1109\/42.650882","article-title":"Volumetric transformation of brain anatomy","volume":"16","author":"Christensen","year":"1997","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib10","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","article-title":"Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?","volume":"60","author":"Clark","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib11","series-title":"The Neuropsychiatric Inventory","author":"Cummings","year":"2005"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib12","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with two- [(18)F] fluoro-2-deoxy-d-glucose\/poitronemission tomography (FDG\/PET)","volume":"98","author":"de Leon","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F] FDG PET study","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib15","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1212\/WNL.0b013e3181a2e896","article-title":"In vivo mapping of amyloid toxicity in Alzheimer disease","volume":"72","author":"Frisoni","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib17","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1212\/WNL.58.10.1476","article-title":"Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study","volume":"58","author":"Gosche","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer's disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib20","first-page":"1920","article-title":"FDG PET imaging in patients with pathologically verified dementia","volume":"41","author":"Hoffman","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmri.10163","article-title":"Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia","volume":"16","author":"Hsu","year":"2002","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib22","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib23","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.55.4.484","article-title":"Rates of hippocampal atrophy correlate with change in clinical status in aging and Alzheimer's disease","volume":"55","author":"Jack","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib26","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1212\/01.wnl.0000281688.77598.35","article-title":"Atrophy rates accelerate in amnestic mild cognitive impairment","volume":"70","author":"Jack","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib27","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Alzheimer's Disease Neuroimaging","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.20799","article-title":"Brain imaging evidence of preclinical Alzheimer's disease in normal aging","volume":"59","author":"Jagust","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/01.wnl.0000269790.05105.16","article-title":"What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?","volume":"69","author":"Jagust","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","article-title":"Relationships between biomarkers in aging and dementia","volume":"73","author":"Jagust","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib32","series-title":"The Boston Naming Test","author":"Kaplan","year":"1982"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib33","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","article-title":"Simultaneous measurement of beta-amyloid(1\u201342), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology","volume":"51","author":"Olsson","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1673\/031.003.3401","article-title":"Overlapping confidence intervals or standard error intervals: What do they mean in terms of statistical significance?","volume":"3","author":"Payton","year":"2003","journal-title":"J Insect Sci"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E","volume":"334","author":"Reiman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.410440226","article-title":"Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease","volume":"44","author":"Reiman","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trail-Making Test as an indication of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib42","series-title":"l'Examen Clinique en Psychologie","author":"Rey","year":"1964"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1474-4422(06)70550-6","article-title":"Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study","volume":"5","author":"Ridha","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib44","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib45","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib46","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neurobiolaging.2006.11.018","article-title":"CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease","volume":"29","author":"Schoonenboom","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib47","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/awp007","article-title":"MRI Of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers","volume":"132","author":"Schuff","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2176","article-title":"Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics","volume":"6","author":"Shaw","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/01.WNL.0000079053.77227.14","article-title":"Changes in premorbid brain volume predict Alzheimer's disease pathology","volume":"61","author":"Silbert","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib51","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jama.273.12.942","article-title":"Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease","volume":"273","author":"Small","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib52","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid forty-two and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/jnnp.2005.075341","article-title":"Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease","volume":"77","author":"Van de Pol","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib54","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.0b013e3181af79e5","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ana.21953","article-title":"Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease","volume":"67","author":"Vemuri","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib56","series-title":"Wechsler Adult Intelligence Scale\u2013Revised","author":"Wechsler","year":"1987"},{"key":"10.1016\/j.neurobiolaging.2010.04.024_bib57","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ana.20503","article-title":"Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia","volume":"57","author":"Zarow","year":"2005","journal-title":"Ann Neurol"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458010001892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458010001892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:41:14Z","timestamp":1711554074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458010001892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0197458010001892"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.04.024","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}